Elbit Medical Technologies Ltd (EMTC-M.TA)
ILA 16.1
(6.62%)
ILA 16.1
(6.62%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.64 Million USD | -549.21% |
| 2022 | -254 Thousand USD | 92.75% |
| 2021 | -3.5 Million USD | -113.19% |
| 2020 | 26.56 Million USD | -42.44% |
| 2019 | 46.15 Million USD | 22.5% |
| 2018 | 37.67 Million USD | -11.11% |
| 2017 | 42.38 Million USD | 14.21% |
| 2016 | 37.11 Million USD | 9.87% |
| 2015 | 33.77 Million USD | 6.76% |
| 2014 | 31.63 Million USD | 6.25% |
| 2013 | 29.77 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.43 Million USD | 12.8% |
| 2024 Q2 | -1.43 Million USD | 0.0% |
| 2023 Q2 | -1.88 Million USD | 0.0% |
| 2023 FY | -1.64 Million USD | -549.21% |
| 2023 Q4 | -1.64 Million USD | 0.0% |
| 2023 Q3 | -1.64 Million USD | 12.57% |
| 2023 Q1 | -1.88 Million USD | -642.52% |
| 2022 Q4 | -254 Thousand USD | 0.0% |
| 2022 Q1 | -2.63 Million USD | 24.94% |
| 2022 Q2 | -2.63 Million USD | 0.0% |
| 2022 FY | -254 Thousand USD | 92.75% |
| 2022 Q3 | -254 Thousand USD | 90.35% |
| 2021 Q2 | 28.01 Million USD | 5.08% |
| 2021 FY | -3.5 Million USD | -113.19% |
| 2021 Q4 | -3.5 Million USD | 0.0% |
| 2021 Q1 | 26.66 Million USD | 0.38% |
| 2021 Q3 | -3.5 Million USD | -112.51% |
| 2020 Q4 | 26.56 Million USD | -2.4% |
| 2020 FY | 26.56 Million USD | -42.44% |
| 2020 Q1 | 45.59 Million USD | -1.2% |
| 2020 Q2 | 28.9 Million USD | -36.61% |
| 2020 Q3 | 27.21 Million USD | -5.83% |
| 2019 Q3 | 44.11 Million USD | 5.71% |
| 2019 Q2 | 41.72 Million USD | 4.63% |
| 2019 FY | 46.15 Million USD | 22.5% |
| 2019 Q1 | 39.88 Million USD | 5.86% |
| 2019 Q4 | 46.15 Million USD | 4.62% |
| 2018 FY | 37.67 Million USD | -11.11% |
| 2018 Q2 | 36.56 Million USD | 114175.0% |
| 2018 Q1 | 32 Thousand USD | -99.92% |
| 2018 Q4 | 37.67 Million USD | 0.0% |
| 2017 FY | 42.38 Million USD | 14.21% |
| 2017 Q1 | 40.61 Million USD | 9.45% |
| 2017 Q2 | 40.61 Million USD | 0.0% |
| 2017 Q3 | 42.38 Million USD | 4.35% |
| 2017 Q4 | 42.38 Million USD | 0.0% |
| 2016 FY | 37.11 Million USD | 9.87% |
| 2016 Q4 | 37.11 Million USD | -0.66% |
| 2016 Q3 | 37.35 Million USD | 4.89% |
| 2016 Q2 | 35.61 Million USD | 1.68% |
| 2016 Q1 | 35.02 Million USD | 3.7% |
| 2015 FY | 33.77 Million USD | 6.76% |
| 2015 Q1 | 30.93 Million USD | -2.24% |
| 2015 Q2 | 32.75 Million USD | 5.9% |
| 2015 Q3 | 32.76 Million USD | 0.02% |
| 2015 Q4 | 33.77 Million USD | 3.1% |
| 2014 Q1 | 31.11 Million USD | 4.5% |
| 2014 Q3 | 31.55 Million USD | -1.28% |
| 2014 Q4 | 31.63 Million USD | 0.26% |
| 2014 Q2 | 31.96 Million USD | 2.73% |
| 2014 FY | 31.63 Million USD | 6.25% |
| 2013 Q4 | 29.77 Million USD | 4.48% |
| 2013 Q3 | 28.49 Million USD | -4.51% |
| 2013 Q1 | 28.63 Million USD | 0.0% |
| 2013 FY | 29.77 Million USD | 0.0% |
| 2013 Q2 | 29.84 Million USD | 4.24% |
| Name | Net Debt | Net Debt Difference |
|---|